Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease
Public ClinicalTrials.gov record NCT02496884. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-controlled Safety Study of DS-5565 for Treatment of Pain Due to Fibromyalgia in Subjects With Chronic Kidney Disease
Study identification
- NCT ID
- NCT02496884
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Daiichi Sankyo
- Industry
- Enrollment
- 56 participants
Conditions and interventions
Conditions
Interventions
- DS-5565 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 25, 2015
- Primary completion
- Jul 5, 2017
- Completion
- Jul 5, 2017
- Last update posted
- Nov 23, 2020
2015 – 2017
United States locations
- U.S. sites
- 22
- U.S. states
- 14
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Phoenix | Arizona | 85018 | — |
| Not listed | Colton | California | 92324 | — |
| Not listed | Los Angeles | California | 90033 | — |
| Not listed | Santa Ana | California | 92705 | — |
| Not listed | Colorado Springs | Colorado | 80918 | — |
| Not listed | Brooksville | Florida | 34601 | — |
| Not listed | DeBary | Florida | 32713 | — |
| Not listed | Hialeah | Florida | 33013 | — |
| Not listed | Kissimmee | Florida | 34744 | — |
| Not listed | Miami | Florida | 33144 | — |
| Not listed | Grand Blanc | Michigan | 48439 | — |
| Not listed | High Point | North Carolina | 27262 | — |
| Not listed | Cincinnati | Ohio | 45224 | — |
| Not listed | Wyomissing | Pennsylvania | 19610 | — |
| Not listed | Greer | South Carolina | 29651 | — |
| Not listed | Rapid City | South Dakota | 57702 | — |
| Not listed | Knoxville | Tennessee | 37919 | — |
| Not listed | Houston | Texas | 77098 | — |
| Not listed | Plano | Texas | 75093 | — |
| Not listed | Bellevue | Washington | 98007 | — |
| Not listed | Charleston | West Virginia | 25304 | — |
| Not listed | Morgantown | West Virginia | 26505 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02496884, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 23, 2020 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02496884 live on ClinicalTrials.gov.